Coherus BioSciences, Inc. Quarterly Interest Expense in USD from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Coherus BioSciences, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2013 to Q2 2024.
  • Coherus BioSciences, Inc. Interest Expense for the quarter ending June 30, 2024 was $5.33M, a 46.4% decline year-over-year.
  • Coherus BioSciences, Inc. Interest Expense for the twelve months ending June 30, 2024 was $37.3M, a 2.07% increase year-over-year.
  • Coherus BioSciences, Inc. annual Interest Expense for 2023 was $40.5M, a 24.8% increase from 2022.
  • Coherus BioSciences, Inc. annual Interest Expense for 2022 was $32.5M, a 41.4% increase from 2021.
  • Coherus BioSciences, Inc. annual Interest Expense for 2021 was $23M, a 8.47% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $37.3M $5.33M -$4.61M -46.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $41.9M $11.1M +$1.4M +14.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $40.5M $10.6M +$1.23M +13.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $39.3M $10.3M +$2.73M +36.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $36.6M $9.94M +$3.36M +51.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $33.2M $9.71M +$743K +8.28% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $32.5M $9.39M +$3.59M +62% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $28.9M $7.54M +$1.77M +30.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $27.1M $6.58M +$833K +14.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $26.3M $8.97M +$3.32M +58.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $23M $5.79M +$122K +2.15% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 $22.8M $5.77M +$115K +2.03% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $22.7M $5.75M +$339K +6.27% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $22.4M $5.65M +$1.22M +27.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $21.2M $5.67M +$1.19M +26.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $20M $5.66M +$1.19M +26.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $18.8M $5.41M +$975K +22% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $17.8M $4.43M +$215K +5.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $17.6M $4.48M +$2.05M +84.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $15.6M $4.47M +$2.04M +84.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $13.5M $4.43M +$2.02M +83.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $11.5M $4.22M +$1.81M +75.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $9.68M $2.43M +$34K +1.42% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $9.65M $2.43M +$33K +1.38% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $9.62M $2.42M +$33K +1.38% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $9.58M $2.41M +$32K +1.35% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $9.55M $2.4M +$31K +1.31% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $9.52M $2.39M -$28K -1.16% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $9.55M $2.38M +$30K +1.27% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $9.52M $2.38M +$1.54M +184% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $7.98M $2.37M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $2.42M +$2.39M +7233% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $2.35M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $837K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q3 2015 $33K +$32K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q4 2014 $3.9M $0 Oct 1, 2014 Dec 31, 2014 10-K 2017-03-14
Q3 2014 $1K* -$1.99M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $1.16M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $2.74M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 $1.99M Jul 1, 2013 Sep 30, 2013 10-Q 2014-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.